Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Chronic Traumatic Encephalopathy Within an Amyotrophic Lateral Sclerosis Brain Bank Cohort.

Walt GS, Burris HM, Brady CB, Spencer KR, Alvarez VE, Huber BR, Guilderson L, Abdul Rauf N, Collins D, Singh T, Mathias R, Averill JG, Walker SE, Robey I, McKee AC, Kowall NW, Stein TD.

J Neuropathol Exp Neurol. 2018 Dec 1;77(12):1091-1100. doi: 10.1093/jnen/nly092.

PMID:
30299493
2.

Ex Vivo Cytokine Release, Determined by a Multiplex Cytokine Assay, in Response to Coccidioidal Antigen Stimulation of Whole Blood among Subjects with Recently Diagnosed Primary Pulmonary Coccidioidomycosis.

Ampel NM, Robey I, Nguyen CT, Roller B, August J, Knox KS, Pappagianis D.

mSphere. 2018 May 16;3(3). pii: e00065-18. doi: 10.1128/mSphere.00065-18. eCollection 2018 May-Jun.

3.

Enhanced Antibody Detection and Diagnosis of Coccidioidomycosis with the MiraVista IgG and IgM Detection Enzyme Immunoassay.

Malo J, Holbrook E, Zangeneh T, Strawter C, Oren E, Robey I, Erickson H, Chahal R, Durkin M, Thompson C, Hoover SE, Ampel NM, Wheat LJ, Knox KS.

J Clin Microbiol. 2017 Mar;55(3):893-901. doi: 10.1128/JCM.01880-16. Epub 2017 Jan 4.

4.

Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI.

Chen LQ, Howison CM, Jeffery JJ, Robey IF, Kuo PH, Pagel MD.

Magn Reson Med. 2014 Nov;72(5):1408-17. doi: 10.1002/mrm.25053. Epub 2013 Nov 26.

5.

Investigating mechanisms of alkalinization for reducing primary breast tumor invasion.

Robey IF, Nesbit LA.

Biomed Res Int. 2013;2013:485196. doi: 10.1155/2013/485196. Epub 2013 Jul 10.

6.

Multimodality pH imaging in a mouse dorsal skin fold window chamber model.

Leung HM, Schafer R, Pagel MM, Robey IF, Gmitro AF.

Proc SPIE Int Soc Opt Eng. 2013 Feb 2;8574. pii: 85740L. Epub 2013 Mar 13.

7.

Examining the relationship between diet-induced acidosis and cancer.

Robey IF.

Nutr Metab (Lond). 2012 Aug 1;9(1):72. doi: 10.1186/1743-7075-9-72.

8.

Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study.

Martin NK, Robey IF, Gaffney EA, Gillies RJ, Gatenby RA, Maini PK.

Br J Cancer. 2012 Mar 27;106(7):1280-7. doi: 10.1038/bjc.2012.58. Epub 2012 Mar 1.

9.

Bicarbonate and dichloroacetate: evaluating pH altering therapies in a mouse model for metastatic breast cancer.

Robey IF, Martin NK.

BMC Cancer. 2011 Jun 10;11:235. doi: 10.1186/1471-2407-11-235.

10.

A mathematical model of tumour and blood pHe regulation: The HCO3-/CO2 buffering system.

Martin NK, Gaffney EA, Gatenby RA, Gillies RJ, Robey IF, Maini PK.

Math Biosci. 2011 Mar;230(1):1-11. doi: 10.1016/j.mbs.2010.12.002. Epub 2010 Dec 15.

11.

Bicarbonate increases tumor pH and inhibits spontaneous metastases.

Robey IF, Baggett BK, Kirkpatrick ND, Roe DJ, Dosescu J, Sloane BF, Hashim AI, Morse DL, Raghunand N, Gatenby RA, Gillies RJ.

Cancer Res. 2009 Mar 15;69(6):2260-8. doi: 10.1158/0008-5472.CAN-07-5575. Epub 2009 Mar 10.

12.

Regulation of the Warburg effect in early-passage breast cancer cells.

Robey IF, Stephen RM, Brown KS, Baggett BK, Gatenby RA, Gillies RJ.

Neoplasia. 2008 Aug;10(8):745-56.

13.

Causes and consequences of increased glucose metabolism of cancers.

Gillies RJ, Robey I, Gatenby RA.

J Nucl Med. 2008 Jun;49 Suppl 2:24S-42S. doi: 10.2967/jnumed.107.047258. Review.

14.

Natural and autoantibodies to human T-cell receptor Vbeta segments: potential roles in immunomodulation.

Adelman MK, Schluter SF, Robey IF, Marchalonis JJ.

Crit Rev Immunol. 2007;27(3):221-32. Review.

PMID:
18197818
15.

Metabolite changes in HT-29 xenograft tumors following HIF-1alpha inhibition with PX-478 as studied by MR spectroscopy in vivo and ex vivo.

Jordan BF, Black K, Robey IF, Runquist M, Powis G, Gillies RJ.

NMR Biomed. 2005 Nov;18(7):430-9.

PMID:
16206237
16.

Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors.

Robey IF, Lien AD, Welsh SJ, Baggett BK, Gillies RJ.

Neoplasia. 2005 Apr;7(4):324-30.

17.

Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice.

Robey IF, Peterson M, Horwitz MS, Kono DH, Stratmann T, Theofilopoulos AN, Sarvetnick N, Teyton L, Feeney AJ.

J Immunol. 2004 Apr 1;172(7):4624-9.

18.

Human monoclonal natural autoantibodies against the T-cell receptor inhibit interleukin-2 production in murine T cells.

Robey IF, Schluter SF, Akporiaye E, Yocum DE, Marchalonis JJ.

Immunology. 2002 Apr;105(4):419-29.

19.

Specificity mapping of human anti-T cell receptor monoclonal natural antibodies: defining the properties of epitope recognition promiscuity.

Robey IF, Edmundson AB, Schluter SF, Yocum DE, Marchalonis JJ.

FASEB J. 2002 May;16(7):642-52.

PMID:
11978728
20.

T-cell receptor-derived peptides in immunoregulation and therapy of retrovirally induced immunosuppression.

Marchalonis JJ, Robey IF, Edmundson AB, Sepulveda RT, Watson RR.

Crit Rev Immunol. 2001;21(1-3):57-74. Review.

PMID:
11642614
21.

Exquisite specificity and peptide epitope recognition promiscuity, properties shared by antibodies from sharks to humans.

Marchalonis JJ, Adelman MK, Robey IF, Schluter SF, Edmundson AB.

J Mol Recognit. 2001 Mar-Apr;14(2):110-21. Review.

PMID:
11301481
22.

Production and characterization of monoclonal IgM autoantibodies specific for the T-cell receptor.

Robey IF, Schluter SF, Yocum DE, Marchalonis JJ.

J Protein Chem. 2000 Jan;19(1):9-21.

PMID:
10882168
23.

Epitope promiscuity of human monoclonal autoantibodies to T-cell receptor-combining site determinants.

Marchalonis JJ, Robey I, Schluter SF, Yocum DE.

Appl Biochem Biotechnol. 2000 Jan-Mar;83(1-3):31-49; discussion 49-52, 145-53.

PMID:
10826947
24.

Differential susceptibility of human T(h)1 versus T(h) 2 cells to induction of anergy and apoptosis by ECDI/antigen-coupled antigen-presenting cells.

Vandenbark AA, Barnes D, Finn T, Bourdette DN, Whitham R, Robey I, Kaleeba J, Bebo BF Jr, Miller SD, Offner H, Chou YK.

Int Immunol. 2000 Jan;12(1):57-66.

PMID:
10607750
25.

IL-7 enhances Ag-specific human T cell response by increasing expression of IL-2R alpha and gamma chains.

Chou YK, Bourdette DN, Barnes D, Finn TP, Murray S, Unsicker L, Robey I, Whitham RH, Buenafe AC, Allegretta M, Offner H, Vandenbark AA.

J Neuroimmunol. 1999 Apr 1;96(1):101-11.

PMID:
10227429
26.

Induction of T cell anergy by high concentrations of immunodominant native peptide is accompanied by IL-10 production and a block in JNK activity.

Chou YK, Robey I, Woody CN, Li W, Offner H, Vandenbark AA, Davey MP.

Cell Immunol. 1998 Sep 15;188(2):125-36.

PMID:
9756643
27.

Novel adjuvants for induction of T-cell and antibody responses to encephalitogenic and regulatory determinants in Lewis rats.

Ariail KS, Bebo BF, Adlard K, Robey I, Burrows G, Newman MJ, Todd CW, Vandenbark AA, Offner H.

Vaccine. 1998 Jan;16(1):99-108.

PMID:
9607016
28.

MHC-restriction, cytokine profile, and immunoregulatory effects of human T cells specific for TCR V beta CDR2 peptides: comparison with myelin basic protein-specific T cells.

Chou YK, Weinberg AD, Buenafe A, Bourdette DN, Whitham R, Kaleeba JA, Robey IF, Kavanagh DG, Offner H, Vandenbark AA.

J Neurosci Res. 1996 Sep 15;45(6):838-51.

PMID:
8892096
29.

Supplemental Content

Support Center